Lucinda Y. Quan

Insider Reports History

Entity
Individual
Location
C/O Aligos Therapeutics, Inc., One Corporate Drive, 2 Nd Floor, South San Francisco, CA
Signature
/s/ Lucinda Y. Quan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lucinda Y. Quan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. Executive Vice President, Chief Business Officer and General Counsel Stock Option (Right to Buy) 48K Sep 8, 2023 Direct

Insider Reports Filed by Lucinda Y. Quan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALGS Aligos Therapeutics, Inc. Sep 8, 2023 1 $0 4 Sep 12, 2023 Executive Vice President, Chief Business Officer and General Counsel
ALGS Aligos Therapeutics, Inc. Mar 15, 2023 1 $0 4 Mar 17, 2023 Executive Vice President, Chief Business Officer and General Counsel
ALGS Aligos Therapeutics, Inc. Jul 7, 2022 1 $0 4 Jul 11, 2022 Executive Vice President, Chief Business Officer and General Counsel
ALGS Aligos Therapeutics, Inc. Feb 4, 2022 2 $0 4 Feb 8, 2022 Executive Vice President, Chief Business Officer and General Counsel